Dr Silver

September 20, 2016
ropeginterferon

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Key points The novel IFNα-2b AOP2014 administered once every two weeks (or once a month) has low toxicity and induces high and sustained response rates in […]
August 5, 2016
hematocrit in PV, Dr Silver explains

Current Treatment Developments in Polycythemia Vera

[contentcards url=”https://www.youtube.com/watch?v=M6yVH8WFQeg&sns=em&app=desktop” target=”_blank”] This video is outstanding, well worth watching! Dr Silver and Dr Gisslinger in Europe have been using interferon successfully for 30 years.  It […]
Do NOT follow this link or you will be banned from the site!
Malcare WordPress Security